IP Library Patent Application 11544568
Patent Application
App. No. 11/544,568

CoEnzyme Q10 formulation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/544,568
Abstract

The formula contains a combination of nutrients ideal for cardiovascular health. Coenzyme Q10 (CoQ10), tocotrienols and tocopherols (potent forms of vitamin E) promote healthy heart function, provide powerful antioxidant protection and support the immune system in its daily defense of the body. The formula also contains a unique tocotrienol complex, derived from the fruit oil of palm trees. Tocotrienols (also known as “super vitamin E”) have been clinically proven to promote healthy cholesterol levels. They inhibit production of cholesterol in the liver and may actually be able to reverse arterial blockage, promoting efficient blood flow supply to the heart muscle.

Claims (29)

1 . A formulation comprising

Coenzyme Q10 and a second component selected from the group consisting of g-gamma tocopherol, tocotrienol and Black Pepper Extract.

2 . The formulation of claim 1 wherein said second component is g-gamma tocopherol.

3 . The formulation of claim 1 wherein said second component is tocotrienol.

4 . The formulation of claim 1 wherein said second component is Black Pepper Extract.

5 . The formulation of claim 4 further comprising 0.5-500 mg Black Pepper Extract.

6 . The formulation of claim 5 further comprising 5 mg Black Pepper Extract.

7 . The formulation of claim 1 further comprising rice bran oil.

8 . A formulation comprising

Tocopherols & Tocotrienols and

Coenzyme Q10.

9 . The formulation of claim 8 , wherein said Tocopherols & Tocotrienols comprises

2.5-2500 mg d-gamma tocopherol,

1-1000 mg d-delta tocopherol,

0.68-6800 mg d-alpha tocopherol,

83.4-83400 mcg d-beta tocopherol,

0.17-1700 mg d-gamma tocotrienol,

92-92000 mcg d-alpha tocotrienol,

44-44000 mcg d-delta tocotrienol, and

12-12000 mcg d-beta tocotrienol.

10 . The formulation of claim 9 wherein said Tocopherols & Tocotrienols comprises

25 mg d-gamma tocopherol,

10 mg d-delta tocopherol,

6.8 mg d-alpha tocopherol,

834 mcg d-beta tocopherol,

1.7 mg d-gamma tocotrienol,

920 mcg d-alpha tocotrienol,

440 mcg d-delta tocotrienol, and

120 mcg d-beta tocotrienol.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION (AS SUCCESSOR BY MERGER TO WACHOVIA BANK, NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: VITACOST.COM INC.
Reel/Frame 033525/0029 →
EMPLOYMENT, NON-COMPETITION AND PROPRIETARY RIGHTS AGREEMENT Recorded Apr 25, 2011
From: GORSEK, WAYNE
To: VITACOST.COM INC.
Reel/Frame 026178/0890 →
SECURITY AGREEMENT Recorded Aug 24, 2007
From: VITACOST.COM INC.
To: WACHOVIA BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 019733/0790 →